Drugs

SJR Rank #549H-index: 212SJR: 3.500Best quartile: Q1Open AccessAPC: US$5,990
Journal website: aims, scope and author guidelines
Publisher

Country

Switzerland

Type

journal

SJR by Edition

2022202500.91.82.73.6

Subject Categories

  • Pharmacology (medical)Q1

Areas: Medicine

Most published research topics

Antibiotics Pharmacokinetics and EfficacyBlood Pressure and Hypertension StudiesAntibiotic Resistance in BacteriaAsthma and respiratory diseasesCancer Treatment and PharmacologyPneumonia and Respiratory InfectionsDiabetes Treatment and ManagementInflammatory mediators and NSAID effectsCardiac electrophysiology and arrhythmiasPharmacological Effects and Toxicity Studies

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0150300450600

Documents per Year

2022202504080120160

Detailed Information

ISSN

0012-6667, 1179-1950

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

13.28

References per Document

68.12

Coverage

1971-2026

Scope

Drugs promotes optimum pharmacotherapy by providing a programme of review and original research articles on the most important aspects of clinical pharmacology and therapeutics. The Journal includes: -Leading/current opinion articles providing an overview of contentious or emerging issues. -Definitive reviews of drugs and drug classes, and their place in disease management. -Therapy in Practice articles including recommendations for specific clinical situations. -High-quality, well designed, original clinical research. -Adis Drug Evaluations reviewing the properties and place in therapy of both newer and established drugs. -AdisInsight Reports summarising development at first global approval. Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Drugs may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.

Metrics from SCImago Journal Rank 2025. View on SCImago